Jiyan Biotech Sincerely Seeking Agents

In order to bring convenient and high-quality products and services to more researchers, we are now sincerely inviting agents from all regions to join us. We are committed to expanding the organoid reagent and service business!

Why US?

   Diverse Product Range

Over 50 organoid construction kits from sources like tumors, normal tissues and mice.

   Favorable Agency Terms

Product - advantage discounts, full - line promotional support, online team training, joint campus tours, and promotional materials support.

   Solid Technical Foundation

We provide on - site technical guidance in the market and are the only one to promise free reconstruction in case of failure.

   Exclusive Market Products

SE-gel, a specialized tissue embedding gel for organoids, is an exclusive product in the market.

For more information, please feel free to contact us. Tel: +86 139 1378 9040

ABOUT Jiyan Biotech

Jiyan Biotech, based in Suzhou, is dedicated to the realm of tumor precision medical services. It focuses on the development of tumor organoid models and the innovation of organ-on-a-chip technology platforms. These are applied to various aspects such as drug sensitivity determination, drug evaluation, research on latent targets, and investigations into the mechanisms of tumor diseases. Thereby, it is able to offer personalized and precise treatment strategies for patients and present a novel in vitro evaluation paradigm for new drug discovery and development. Jiyan Biotech has been successively accredited as a national small and medium-sized science and technology enterprise, a private science and technology enterprise in Jiangsu Province, and a national high-tech enterprise.

Currently, the company has its self-developed "one-stop" tumor organoid construction kits and a number of organ-on-a-chip products. It has lodged 26 national patent applications, among which 14 have been granted. With the motto of "Contributing to the World and Probing into the Depths of Research", Jiyan Biotech is committed to furnishing valuable services in the fields of tumor personalized treatment and new drug development.